## 



## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 






## 

## 




## 

## 


## 



## 







## 

## 


## 



## 

## 




## 






## 






## 




## 





## 



## 

|Name||Role||||||
|---|---|---|---|---|---|---|---|
|Jonathan<br>Wade (v)||Chief Executive|(Appointed|1 September 2022)||||
|Tom Clarke (v)||Medical Director (Appointed|||1 September 2022)|||
|Siobhan Callanan|(v)|Chief Nurse||||||
|Guy Dentith<br>(v)||Chief Finance Officer (Appointed||||1 September 2022)||
|Alexandra<br>Bode-Tunji||Chief People Officer||||||
|Bas Sadiq||Director of Improvement||||||
|Tori Harrison||Chief Operating|Officer (Appointed|||9January 2023)||
|Peter Coles<br>(v)||Trust Chair||||||
|Lynn Gladwell<br>(v)||Non-Executive|Director and||Chair|ofthe Charitable|Funds Committee|
|Gill Jenner (v)||Non-Executive|Director and||Chair|ofthe Workforce|Committee|
|David Ahmad<br>(v)||Non-Executive|Director and||Chair|ofthe Audit Committee||
|Suzanne<br>O'Brien|(v)|Non-Executive|Director and||Chair|ofthe Finance Committee||
|Steve Wilmshurst|(v)|Non-Executive|Director and||Chair|ofthe Quality and|Safety|
|||Committee<br>and|Remuneration||Committee|||
|(v) —donates a voting||member ofthe Board||||||
|Name||Change to the Board||||||
|Louise Ashley<br>(v)||Chief Executive|(1 April —31|August 2022)||||
|lan O' Connor (v)||Chief Finance Officer (1 April||—4 September 2022)||||
|Steve Fenlon (v)||Medical Director|(1 April —31||August 2022)|||





|Lynn Gladwell|Non-Executive<br>Director (Chair)|Non-Executive<br>Director (Chair)||
|---|---|---|---|
|Jonathan<br>Wade|Chief Executive|||
|Guy Dentith|Chief Finance Officer|||
|Tori Harrison|Chief Operating<br>Officer|||
|Sally George|Head of Fundraising|and Voluntary|Services|
|Susan Oake|Finance Manager|||
|Jane Burr|Trust Secretary|||
|Djafer Erdogan|Assistant<br>Director of|Finance||



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 



## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 



## 

|||||Unrestricted|Restricted|2022-23|2021-22|
|---|---|---|---|---|---|---|---|
||||Note|Funds|Funds|Total|Total|
|||||||Funds|Funds|
|||||f000|6000|EOOO|EODO|
|Income and endowments||from:||||||
|Donations<br>and legacies||||262|0|262|466|
|Grants||||0|30|30|0|
|Other trading activities||||18|0|18|13|
|Dividends<br>&bank interest||||19|0|19|0|
|Total incoming<br>resources||||299|30|329|479|
|Expenditure<br>on:||||||||
|Raising funds||||70||70|51|
|Charitable<br>activities:||||||||
|Purchase of new equipment||||251||251|232|
|Staff education<br>and welfare||||88||89|113|
|Patient education<br>and|welfare|||37||37|15|
|Total resources expended|||||1|447|411|
|Net movement<br>in funds||||(147)|29|(118)||
|Reconciliation<br>of Funds||||||||
|Total funds brought|forward|||1,036|0|1,036|968|
|Total Funds carried|forward|||889|29|918|1,036|





## 

||||Notes||||Total at|31|Total at 31|
|---|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted||March 2023||March 2022|
|||||6000|6000||6000||EOOD|
|Current Assets||||||||||
|Receivables||||10||0||10|6|
|Prepayments||||14||0||14|18|
|Cash and cash equivalents||||941||29||919||
|Total Current Assets||||965||29||994|1066|
|Current<br>Liabilities||||||||||
|payables: Amounts|falling|||||||||
|due within one|year||10.1|76||||76|28|
|Net Current Assets||||889||29||918|1638|
|Total Assets less Current||Liabilities||889||29||918|1638|
|paya bles: Amounts|falling|||||||||
|due after one year|||10.2|||||0|2|
|Total net assets or liabilities||||889||29||918|1636|
|Funds ofthe Charity||||||||||
|Income Funds:||||||||||
|Funds||||889||29||918|1,036|
|Total Funds||||889||29||918|1,036|





## 

|||2022-23|2021-22|
|---|---|---|---|
|||Total|Total|
|||Funds|Funds|
|||EOOD|EOOO|
|Cash Flows from Operating<br>Activities||||
|Net movement<br>in funds<br>(Increase)/Decrease<br>in1rade and Other Receivables<br>(Decrease)/Increase<br>in1rade and Other Payables||(118)<br>0<br>46|68<br>18<br>~49|
|Net cash (used in) by Operating<br>Activities<br>Change<br>in cash and cash equivalents<br>in the reporting|period|(72)<br>~22|41<br>41|
|NET INCREASE/(DECREASE)<br>IN CASH AND CASH EQUIVALENTS||(72)|41|
|Cash and Cash Equivalents<br>at Beginning ofthe Period||1,042|1,001|
|Cash and Cash Equivalents<br>at year end||9'fD|1 D42|





## 

## 

## 






|3|Donations|and legacies|2023|2022|
|---|---|---|---|---|
||||Total|Total|
||||fooc|fcco|
||Donations||182|207|
||Legaaes||80|259|
||Grants||30|0|
||||292|466|
||In 2021-22 the charity received a large legacy for 6238,457||||
||Other trading activities||2023|2022|
||||Total|Total|
||||fooc|5000|
||Stride4Life||5|6|
||Training|Course income|3|3|
||Xmas Draw||3|4|
||Golf Day|Income|5|0|
||Market Event Income||||
|||||13|



## 

||||Grant|Support|Total|
|---|---|---|---|---|---|
||||funded|costs||
||||activity|||
||||EOOD|5000|EOOD|
|Purchase ofnew||equipment|228|23|251|
|Staff Education|and Welfare||81|8|89|
|Patient Education||and Welfare|33|4|37|
|Total|||342|35|377|



## 



|9|Analysisofcurrentassets|2023|2022|
|---|---|---|---|
|||Total|Total|
|||FOOD|FOOD|
||Receivables|1D|6|
||Prepayments|14|18|
||Cash and cash equivalents|970|1042|
||Total|994|1066|



|Analysis ofcurrentliabilities|||
|---|---|---|
||2023|2022|
||Total|Total|
||0000|EOOD|
|Accruals|7|8|
|Payables|69|20|
|Total|76|28|
|Analysisofnonmurrentgabgiaes|||
||2023|2022|
||Total|Total|
||FOOD|FOOD|
|Accruals|||
|Total|0|2|





## 

|The Trust has analys|The Trust has analys|ed matenal|ed matenal|designated|fund balances as set out below:|||||
|---|---|---|---|---|---|---|---|---|---|
|Fund Name|||||Fund|Balance|Incoming|Outgoing|Fund Balances|
||||||broughtforward||Resources|Resources|cardied forward|
|||||||6||6||
|Breast Care Ubrary||Trust Fund||||6,579|9,427|585|15,421|
|Cancer Fightmg Fund||||||192,804|21,845|28,118|186,531|
|Cardiology Training||Fund||||18,329|0|1,861|16,467|
|Diagnostics<br>Fund||||||12,082|D|675|11,407|
|Fnends Fund<br>Staff||||||215,477|166,719|158,283|223,913|
|Heartbeat<br>Fund||||||264,731|6,975|32,506|239,199|
|Little Buds Fund<br>Iyegbeing||||||87,652|19,942|74,911|32,683|
|Lollipop Fund||||||13,612|13,350|16,086|10,877|
|Lottery Fund||||||8,239|5,897|626|13,510|
||Fun|||||149,217|6,712|113,310|42,620|
|Urology Research|Fund|||||24,994|6,700|3,582|28,113|
|Valley Fund||||||1,766|20,204|2,120|19,850|
|OtherFunds||||||41234|21374|13873|48 735|
|Totaldesignated||Funds||||1,036,716|299,145|446,836|889,326|
|Development<br>Grant||- RESTRICTED||||||||
|Total restricted|funds||||||30,000|1,200|28,800|
|TOTAL FUNDS||||||1,036,716|329,145|447,736|918,126|
|Otherfunds<br>are aglessthan|||610k.|||||||



